Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Nixon

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Immunology|January 5, 2011
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionC Kuylenstierna, J E Snyder-Cappione, C P Loo, et al.
AIDS (London, England)|September 21, 2000
Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surfaceB L Shacklett, S Cu-Uvin, T J Beadle, et al.
Journal of Virology|December 19, 2000
Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19T Tolfvenstam, A Oxenius, D A Price, et al.
Nature|December 12, 1991
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognitionR E Phillips, S Rowland-Jones, D F Nixon, et al.
Journal of Virology|January 7, 2000
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cellsH M Spiegel, G S Ogg, E DeFalcon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjectsG M Ortiz, M Wellons, J Brancato, et al.
AIDS (London, England)|June 21, 2001
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infectionF García, M Plana, G M Ortiz, et al.
The Journal of Infectious Diseases|July 9, 1999
Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in childrenH M Spiegel, E DeFalcon, G S Ogg, et al.
Vaccine|April 1, 1996
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesC E Hioe, H Qiu, P D Chend, et al.
Vaccine|November 1, 1996
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activityD F Nixon, C Hioe, P D Chen, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Immunology|January 5, 2011
NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionC Kuylenstierna, J E Snyder-Cappione, C P Loo, et al.
AIDS (London, England)|September 21, 2000
Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surfaceB L Shacklett, S Cu-Uvin, T J Beadle, et al.
Journal of Virology|December 19, 2000
Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19T Tolfvenstam, A Oxenius, D A Price, et al.
Nature|December 12, 1991
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognitionR E Phillips, S Rowland-Jones, D F Nixon, et al.
Journal of Virology|January 7, 2000
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cellsH M Spiegel, G S Ogg, E DeFalcon, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2001
Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjectsG M Ortiz, M Wellons, J Brancato, et al.
AIDS (London, England)|June 21, 2001
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infectionF García, M Plana, G M Ortiz, et al.
The Journal of Infectious Diseases|July 9, 1999
Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in childrenH M Spiegel, E DeFalcon, G S Ogg, et al.
Vaccine|April 1, 1996
Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesC E Hioe, H Qiu, P D Chend, et al.
Vaccine|November 1, 1996
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activityD F Nixon, C Hioe, P D Chen, et al.
Pageof 6